KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cvs Health (CVS) Receivables (2016 - 2025)

Cvs Health (CVS) has disclosed Receivables for 17 consecutive years, with $13.7 billion as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Receivables fell 69.28% year-over-year to $13.7 billion, compared with a TTM value of $13.7 billion through Dec 2025, down 69.28%, and an annual FY2025 reading of $13.7 billion, down 69.28% over the prior year.
  • Receivables was $13.7 billion for Q4 2025 at Cvs Health, down from $14.9 billion in the prior quarter.
  • Across five years, Receivables topped out at $51.1 billion in Q2 2025 and bottomed at $6.0 billion in Q1 2022.
  • Average Receivables over 5 years is $29.0 billion, with a median of $30.7 billion recorded in 2021.
  • The sharpest move saw Receivables crashed 80.89% in 2022, then surged 669.55% in 2023.
  • Year by year, Receivables stood at $27.8 billion in 2021, then crashed by 77.98% to $6.1 billion in 2022, then soared by 669.55% to $47.1 billion in 2023, then fell by 5.73% to $44.4 billion in 2024, then plummeted by 69.28% to $13.7 billion in 2025.
  • Business Quant data shows Receivables for CVS at $13.7 billion in Q4 2025, $14.9 billion in Q3 2025, and $51.1 billion in Q2 2025.